These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 1388684)
1. Stepwise transformation of primary thyroid epithelial cells by a mutant Ha-ras oncogene: an in vitro model of tumor progression. Burns JS; Blaydes JP; Wright PA; Lemoine L; Bond JA; Williams ED; Wynford-Thomas D Mol Carcinog; 1992; 6(2):129-39. PubMed ID: 1388684 [TBL] [Abstract][Full Text] [Related]
2. Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-alpha genes on in vitro transformation of human mammary epithelial cells. Ciardiello F; Gottardis M; Basolo F; Pepe S; Normanno N; Dickson RB; Bianco AR; Salomon DS Mol Carcinog; 1992; 6(1):43-52. PubMed ID: 1354442 [TBL] [Abstract][Full Text] [Related]
3. Partial transformation of human thyroid epithelial cells by mutant Ha-ras oncogene. Lemoine NR; Staddon S; Bond J; Wyllie FS; Shaw JJ; Wynford-Thomas D Oncogene; 1990 Dec; 5(12):1833-7. PubMed ID: 1704496 [TBL] [Abstract][Full Text] [Related]
4. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype. Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341 [TBL] [Abstract][Full Text] [Related]
5. Correlated abnormalities of transforming growth factor-beta 1 response and p53 expression in thyroid epithelial cell transformation. Wyllie FS; Dawson T; Bond JA; Goretzki P; Game S; Prime S; Wynford-Thomas D Mol Cell Endocrinol; 1991 Apr; 76(1-3):13-21. PubMed ID: 1820969 [TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation. Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145 [TBL] [Abstract][Full Text] [Related]
7. A mutant p53 protein is required for maintenance of the transformed phenotype in cells transformed with p53 plus ras cDNAs. Zambetti GP; Olson D; Labow M; Levine AJ Proc Natl Acad Sci U S A; 1992 May; 89(9):3952-6. PubMed ID: 1570319 [TBL] [Abstract][Full Text] [Related]
8. Interaction between p53 and TGF beta 1 in control of epithelial cell proliferation. Blaydes JP; Schlumberger M; Wynford-Thomas D; Wyllie FS Oncogene; 1995 Jan; 10(2):307-17. PubMed ID: 7838530 [TBL] [Abstract][Full Text] [Related]
9. Transfection and expression of mutant p53 protein does not alter the in vivo or in vitro growth characteristics of the AA/C1 human adenoma derived cell line, including sensitivity to transforming growth factor-beta 1. Williams AC; Browne SJ; Manning AM; Daffada P; Collard TJ; Paraskeva C Oncogene; 1994 May; 9(5):1479-85. PubMed ID: 8152811 [TBL] [Abstract][Full Text] [Related]
10. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice. Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190 [TBL] [Abstract][Full Text] [Related]
11. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. Su ZZ; Austin VN; Zimmer SG; Fisher PB Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744 [TBL] [Abstract][Full Text] [Related]
12. Reversal of ras-induced inhibition of gap-junctional intercellular communication, transformation, and tumorigenesis by lovastatin. Ruch RJ; Madhukar BV; Trosko JE; Klaunig JE Mol Carcinog; 1993; 7(1):50-9. PubMed ID: 8435109 [TBL] [Abstract][Full Text] [Related]
13. In vitro reconstruction of tumour initiation in a human epithelium. Bond JA; Wyllie FS; Rowson J; Radulescu A; Wynford-Thomas D Oncogene; 1994 Jan; 9(1):281-90. PubMed ID: 8302590 [TBL] [Abstract][Full Text] [Related]
14. The p53 tumor suppressor gene and gene product. Levine AJ Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233 [TBL] [Abstract][Full Text] [Related]
15. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma. Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299 [TBL] [Abstract][Full Text] [Related]
16. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta. Manning AM; Williams AC; Game SM; Paraskeva C Oncogene; 1991 Aug; 6(8):1471-6. PubMed ID: 1886718 [TBL] [Abstract][Full Text] [Related]
17. Frameshift mutation in codon 176 of the p53 gene in rat esophageal epithelial cells transformed by benzo[a]pyrene dihydrodiol. Wang D; You L; Sneddon J; Cheng SJ; Jamasbi R; Stoner GD Mol Carcinog; 1995 Oct; 14(2):84-93. PubMed ID: 7576103 [TBL] [Abstract][Full Text] [Related]
18. Reduced levels of alpha 1 (I) collagen mRNA in cells immortalized by mutant p53 or transformed by ras. Eizenberg O; Oren M Biochim Biophys Acta; 1991 Dec; 1129(1):34-42. PubMed ID: 1756178 [TBL] [Abstract][Full Text] [Related]
20. Multiple mechanisms of interference between transformation and differentiation in thyroid cells. Francis-Lang H; Zannini M; De Felice M; Berlingieri MT; Fusco A; Di Lauro R Mol Cell Biol; 1992 Dec; 12(12):5793-800. PubMed ID: 1448106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]